Interestingly, miR-142-5p influences the tumor microenvironment, PD-L1 expression and HCC prognosis by targeting m6A RNA methylation regulators [78], warranting its validation in advanced HCC undergoing immunotherapy. This evidence concerns the gene CD274 and neoplasm.